Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve As Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer.
Frontiers in Oncology（2022）
关键词
neoadjuvant chemotherapy (NAC),pathologic complete response (pCR),PIK3CA mutations,PI3K-AKT pathway,stage II,III breast cancer (BC)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要